← Eichor
Condition: Chemotherapy Induced Pain Neuropathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chemotherapy Induced Pain Neuropathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT05417737Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longi
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT06162403SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
Phase 2 · 7 location(s) · University of Rochester · NCT06614322Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Sin
EARLY_Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT06744816Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients
NA · 2 location(s) · Riphah International University · NCT06737926Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a
Phase N/A · 1 location(s) · University of Palermo · NCT07352514Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy
Phase 2 · 1 location(s) · Yan Yang, MD, Ph.D · NCT04970121Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy
Phase N/A · 1 location(s) · Mayo Clinic · NCT05411523Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Ne
Phase 2 · 1 location(s) · Fox Chase Cancer Center · NCT06914557The Role of TRP Channels in CIPN
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT04415892Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Phase 2 · 25 location(s) · Dogwood Therapeutics Inc. · NCT06848348Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)
Phase 2/Phase 3 · 2 location(s) · Bernardino Clavo, MD, PhD · NCT04299893Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
Phase 2 · 1 location(s) · VM Therapeutics LLC · NCT07072468Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy
NA · 2 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT06834685Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy
Phase 2/Phase 3 · 4 location(s) · University of British Columbia · NCT05786599Evaluation of Effectiveness of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy for Treatment of Chemotherapy Induce
Phase N/A · 5 location(s) · Rijnstate Hospital · NCT07304401Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%.
NA · 1 location(s) · Hospital Ambroise Paré Paris · NCT07602387
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.